Seractide acetate

DB09334ApprovedProtein Based Therapies

Seractide acetate is the acetate salt of full length human corticotropin.

Mechanism: Pharmacologically active on Adrenocorticotropic hormone receptor
Curator reviewed

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Seractide acetate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.